Apogee Therapeutics plans to start a Phase 2 study of an experimental eczema treatment in the first half of 2024 after revealing earlier-than-expected positive data from an initial study in humans.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,